Search Within

Cailian Liu

Formats
  1. Journal Article (31)
  2. Meeting Abstract (29)
Groups
  1. Department of Medicine (60)
  2. Solid Tumor Oncology Division (60)
  3. GSK Faculty (59)
  4. Melanoma and Immunotherapeutics Service (59)
  5. Sloan Kettering Institute Postdocs (46)
  6. Sloan Kettering Institute Faculty (22)

More Groups

People
  1. Jedd Wolchok (56)
  2. Taha Merghoub (49)
  3. Sadna Budhu (30)
  4. Hong Zhong (19)
  5. Roberta Zappasodi (19)
  6. Daniel Hirschhorn Cymerman (16)

More People

Years
  1. 2024 (1)
  2. 2022 (6)
  3. 2021 (5)
  4. 2020 (7)
  5. 2019 (3)
  6. 2018 (11)

More Years

Publications
  1. Cancer Research (12)
  2. Journal for ImmunoTherapy of Cancer (11)
  3. Cancer Cell (4)
  4. Cancer Immunology Research (4)
  5. Journal of Immunology (3)
  6. Blood (2)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. Biomed Central Ltd (11)
  3. Nature Publishing Group (8)
  4. Cell Press (7)
  5. Elsevier Inc. (3)
  6. The American Association of Immunologists, Inc (3)

More Publishers

Results (60)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer
    Journal Article

    Hellmann, M. D.; Nathanson, T.; Rizvi, H.; Creelan, B. C.; Sanchez-Vega, F.; Ahuja, A.; Ni, A.; Novik, J. B.; Mangarin, L. M. B.; Abu-Akeel, M.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Pre-existing immunity to oncolytic virus potentiates its immunotherapeutic efficacy
    Journal Article

    Ricca, J. M.; Oseledchyk, A.; Walther, T.; Liu, C.; Mangarin, L.; Merghoub, T.; Wolchok, J. D.; Zamarin, D.
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Opposing effects of CTLA-4 and PD-1 blockade on follicular helperlike T cells with immunosuppressive functions
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M.; Senbabaoglu, Y.; Gasmi, B.; Zhong, H.; Li, Y.; Liu, C.; Hirschhorhn-Cymerman, D.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
    Journal Article

    De Henau, O.; Rausch, M.; Winkler, D.; Campesato, L. F.; Liu, C.; Cymerman, D. H.; Budhu, S.; Ghosh, A.; Pink, M.; Tchaicha, J.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • Treg inhibition by anti-GITR therapy evokes therapeutic antitumor responses selectively in the context of a pro-inflammatory tumor microenvironment
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Liu, C.; Draleau, K.; Schaer, D.; Zhong, H.; Yang, X.; Merghoub, T.; Wolchok, J. D.
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Clonal abundance of tumor-specific CD4(+) T cells potentiates efficacy and alters susceptibility to exhaustion
    Journal Article

    Malandro, N.; Budhu, S.; Kuhn, N. F.; Liu, C.; Murphy, J. T.; Cortez, C.; Zhong, H.; Yang, X.; Rizzuto, G.; Altan-Bonnet, G.; more...
    Immunity (2016)

    Fulltext@MSK | Save
  • Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
    Journal Article

    Postow, M. A.; Manuel, M.; Wong, P.; Yuan, J.; Dong, Z. W.; Liu, C.; Perez, S.; Tanneau, I.; Noel, M.; Courtier, A.; more...
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • The neoantigen landscape underlying clinical response to ipilimumab
    Meeting Abstract

    Snyder Charen, A.; Makarov, V.; Merghoub, T.; Walsh, L.; Yuan, J.; Miller, M.; Kannan, K.; Postow, M. A.; Elipenahli, C.; Liu, C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save